Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2466 | Acta Biomaterialia | 2007 | 9 Pages |
This work aimed to investigate the use of an organically modified porous silica matrix (poly(methacryloxypropyl)–poly(silsesquioxane); P-MA–PS) as a release system for heparin. The matrices were obtained from methacryloxypropyltrimethoxysilane (MAS) via the sol–gel process under acidic conditions following photochemical polymerization and cross-linking of the organic matrix. Modulation of the polymerization degree of the organic matrix in the range 0–71% allowed adjusting the release kinetics of heparin according to therapeutic needs. It was demonstrated that higher drug loads and a decreasing polymerization degree resulted in a faster release profile of heparin, which followed a square root of time kinetic according to the Higuchi model. The hydrolytic degradation of hybrid xerogel was found to follow a zero-order kinetic whereas the heparin concentration did not show an influence on the degradation rate of the matrix. Since the released heparin retained its biological activity, the P-MA–PS matrices are of clinically interest, e.g. as coating on drug eluting coronary stents.